Package 71921-405-21

{"route": ["ORAL"], "spl_id": "f0ef9361-f06d-4028-97af-183b545f4aea", "openfda": {"nui": ["N0000175635", "N0000175637"], "unii": ["9NDF7JZ4M3"], "rxcui": ["2059015"], "spl_set_id": ["f0ef9361-f06d-4028-97af-183b545f4aea"], "pharm_class_epc": ["Factor Xa Inhibitor [EPC]"], "pharm_class_moa": ["Factor Xa Inhibitors [MoA]"], "manufacturer_name": ["Florida Pharmaceutical Products, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (71921-405-06)", "package_ndc": "71921-405-06", "marketing_start_date": "20250820"}, {"sample": false, "description": "180 TABLET in 1 BOTTLE (71921-405-21)", "package_ndc": "71921-405-21", "marketing_start_date": "20250820"}], "brand_name": "rivaroxaban", "product_id": "71921-405_f0ef9361-f06d-4028-97af-183b545f4aea", "dosage_form": "TABLET", "pharm_class": ["Factor Xa Inhibitor [EPC]", "Factor Xa Inhibitors [MoA]"], "product_ndc": "71921-405", "generic_name": "rivaroxaban", "labeler_name": "Florida Pharmaceutical Products, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "rivaroxaban", "active_ingredients": [{"name": "RIVAROXABAN", "strength": "2.5 mg/1"}], "application_number": "ANDA218445", "marketing_category": "ANDA", "marketing_start_date": "20250820", "listing_expiration_date": "20261231"}